US$ 22.47
ghk cu peptide oral or topical GHK-Cu Understanding Topical GHK-Cu Peptide Benefits
Description
Tivantinib, a staurosporine derivative, is a non-ATP competitive selective small-molecule inhibitor and acts mainly as an anti c-Met inhibitor (Santoro et al., 2013)

S.ZhangR

& Cadenas, E

For anyone exploring neuroprotective peptide strategies , understanding the BDNF-neurodegeneration connection is foundational
